Literature DB >> 18278537

The resection of the azygos vein--necessary or redundant extension of transthoracic esophagectomy?

W Schröder1, D Vallböhmer, M Bludau, A Banczyk, C Gutschow, A H Hölscher.   

Abstract

Due to the increasing use of minimally invasive techniques, some authors have questioned the necessity to dissect the azygos vein as part of the en-bloc esophagectomy in patients with esophageal cancer. This study investigates the nodal clearance associated with resection of the azygos vein. Ninety-two patients with esophageal carcinoma were included in this prospective analysis. In all patients, a standard transthoracic en-bloc esophagectomy was performed including the resection of the azygos vein from the superior vena cava to the level of the diaphragm. After resection, the azygos vein with its adjacent connective tissue was separated from the tubular esophagus. The separated azygos vein specimen was histopathologically examined for the presence of lymph nodes (LN) and possible nodal metastasis. A total of 2,778 LN with a mean of 30.2 LN for each patient were resected. In 60 patients, 216 of 1,666 mediastinal LN (13.0%) were located along the azygos vein. Seven of 39 pN1 patients (17.9%) had LN metastases in the separated azygos vein specimen. In these seven patients, a total of 23 metastatic nodes were detected along the azygos vein. LN metastases along the azygos vein are too frequent to neglect their existence. Therefore, standard en-bloc esophagectomy including dissection of the azygos vein should not be abandoned irrespective of the surgical approach.

Entities:  

Mesh:

Year:  2008        PMID: 18278537     DOI: 10.1007/s11605-008-0487-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  24 in total

1.  Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia.

Authors:  J B Hulscher; J W Van Sandick; G J Offerhaus; H W Tilanus; H Obertop; J J Van Lanschot
Journal:  Br J Surg       Date:  2001-05       Impact factor: 6.939

2.  Strangulation of the reconstructive gastric tube by the azygos arch.

Authors:  Frank Cheau-Feng Lin; Hyde Russell; Mark K Ferguson
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

3.  Guide lines for the clinical and pathologic studies on carcinoma of the esophagus.

Authors: 
Journal:  Jpn J Surg       Date:  1976-06

4.  The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction.

Authors:  S M Dresner; P J Lamb; M K Bennett; N Hayes; S M Griffin
Journal:  Surgery       Date:  2001-01       Impact factor: 3.982

5.  Comparison of the outcomes between open and minimally invasive esophagectomy.

Authors:  Bernard M Smithers; David C Gotley; Ian Martin; Janine M Thomas
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

6.  Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.

Authors:  Paul M Schneider; Stephan E Baldus; Ralf Metzger; Martin Kocher; Rudolf Bongartz; Elfriede Bollschweiler; Hartmut Schaefer; Juergen Thiele; Hans P Dienes; Rolf P Mueller; Arnulf H Hoelscher
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

Review 7.  Ischemic spinal cord syndrome after transthoracic esophagectomy: two cases of a rare neurologic complication.

Authors:  N Zantl; H J Stein; B L Brücher; H Bartels; J R Siewert
Journal:  Dis Esophagus       Date:  2000       Impact factor: 3.429

8.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

9.  Minimally invasive esophagectomy: outcomes in 222 patients.

Authors:  James D Luketich; Miguel Alvelo-Rivera; Percival O Buenaventura; Neil A Christie; James S McCaughan; Virginia R Litle; Philip R Schauer; John M Close; Hiran C Fernando
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

10.  A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation.

Authors:  H Osugi; M Takemura; M Higashino; N Takada; S Lee; H Kinoshita
Journal:  Br J Surg       Date:  2003-01       Impact factor: 6.939

View more
  6 in total

1.  The azygos vein: to resect or not?

Authors:  Judith Boone; Richard van Hillegersberg
Journal:  J Gastrointest Surg       Date:  2008-08-02       Impact factor: 3.452

2.  Preserving the pulmonary vagus nerve branches during thoracoscopic esophagectomy.

Authors:  Teus J Weijs; Jelle P Ruurda; Misha D P Luyer; Grard A P Nieuwenhuijzen; Sylvia van der Horst; Ronald L A W Bleys; Richard van Hillegersberg
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

3.  Acute superior vena cava obstruction following Ivor-Lewis oesophagectomy.

Authors:  A Hay; A Hamouda; N Bland; A Rohatgi; A Botha
Journal:  Ann R Coll Surg Engl       Date:  2010-07-07       Impact factor: 1.891

Review 4.  Surgery of esophageal cancer.

Authors:  F G Uzunoglu; M Reeh; A Kutup; J R Izbicki
Journal:  Langenbecks Arch Surg       Date:  2013-01-25       Impact factor: 3.445

Review 5.  [Esophageal squamous cell carcinoma: pre-operative combined radiochemotherapy from a surgical oncological viewpoint].

Authors:  B L D M Brücher
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

6.  Modified McKeown vs. traditional McKeown minimally invasive esophagectomy in improving short-term efficacy and the quality of life of esophageal cancers: a retrospective comparative cohort study.

Authors:  Ying Chen; Yujie Xie; Hai Zhang; Zuwei Li; Bomeng Wu; Cui Li; Wanli Lin
Journal:  J Gastrointest Oncol       Date:  2022-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.